No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study Academic Article uri icon

Overview

MeSH Major

  • Magnetic Resonance Imaging
  • Multiple Sclerosis
  • White Matter

abstract

  • More daclizumab versus intramuscular interferon beta-1a patients achieved NEDA early in DECIDE, with effects increasing over time.

publication date

  • November 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1177/1352458516683266

PubMed ID

  • 28080250

Additional Document Info

start page

  • 1736

end page

  • 1747

volume

  • 23

number

  • 13